Long-term course of psychiatric disorders in cancer patients: a pilot study by Bringmann, Holger et al.
Long-term course of psychiatric disorders in cancer
patients: a pilot study
Langzeitverlauf psychischer Erkrankungen bei Krebspatienten: eine
Pilotstudie
Abstract
Background:Aboutonethirdofcancerpatientssufferfromapsychiatric
disorder. However, only few studies feature long-term assessment of
Holger Bringmann
1
Susanne Singer
1
psychiatric disease in cancer patients, covering a broad range of dia-
gnoses, and employing high-quality instruments. Michael Höckel
2
Jens-Uwe Stolzenburg
3 Patients and methods: A total of 62 patients underwent assessments
during a 3-year follow-up period after initial cancer diagnosis. The Clin- Oliver Krauß
4
ical Interview for Diagnostic and Statistical Manual of Mental Disorders
Reinhold Schwarz
1
was administered to measure psychiatric morbidity at baseline (t1) and
two follow-ups (t2 and t3). Follow-up assessments took place from 6 to
18months(t2)andfrom24to36months(t3)afterbaseline.Biomedical 1 Abteilung Sozialmedizin,
Universität Leipzig, Germany andpsychosocialfactorswereevaluatedtoidentifypredictorsofpsychi-
atric disorders using univariate and multivariate analyses.
2 Universitätsfrauenklinik
Leipzig, Germany Results: At t1, at least one DSM-IV diagnosis was found in 29% of the
cases. At follow-ups, the frequency of psychiatric morbidity increased
3 Klinik und Poliklinik für
Urologie der Universität
Leipzig, Germany
to 36% at t2 and 44% at t3, respectively. New occurrence of psychiatric
diseaseatfollow-upswas18%att2,and38%,att3.Predictorsofpsychi-
atric disorders were low social support, low physical functioning, meta-
stases, complications of disease, and loss of sportive activity. 4 Parkkrankenhaus Leipzig-
Südost GmbH, Klinik für Conclusion: Persistence and amount of newly diagnosed psychiatric
disorders during three years after cancer treatment should be con- Psychiatrie und
Psychosomatische Medizin,
Leipzig, Germany
sidered in the treatment of cancer patients, especially in individuals
with accordant predictive factors.
Keywords: psychiatric morbidity, DSM-IV, cancer, clinical course,
predictors
Zusammenfassung
Hintergrund: Etwa ein Drittel aller Krebspatienten leidet unter einer
psychischen Erkrankung. Dennoch gibt es bisher nur wenige Studien,
die unter Einschluss eines breiten Diagnosespektrums die psychische
Komorbität von Krebspatienten im Langzeitverlauf mit elaborierten In-
strumenten erfassen.
Patienten und Methoden: Insgesamt 62 Patienten nahmen nach
Krebsdiagnose am gesamten Verlauf der 3-jährigen Studie teil. Das
StrukturierteKlinischeInterviewfürDSM-IVwurdezurErhebungpsychi-
scherErkrankungenbeiAufnahme(t1)sowiezuzweiNachfolgeuntersu-
chungen (t2 and t3) eingesetzt. Die Nachfolgeuntersuchungen fanden
im Zeitraum von 6 bis 18 Monaten (t2) und 24 bis 36 Monaten (t3) nach
der Aufnahmeuntersuchung statt. Biomedizinische und psychosoziale
Einflussgrößen wurden ausgewertet, um Prädiktoren psychischer Er-
krankungen mittels uni- und multivariater Analyse zu bestimmen.
Ergebnisse: Bei Aufnahme erhielten 29% der Patienten eine DSM-IV-
Diagnose. Zu beiden Nachfolgeuntersuchungen zeigte sich ein Anstieg
der Häufigkeit psychischer Erkrankungen mit 36% zu t2 und 44% zu t3.
Ein Neuauftreten psychischer Erkrankungen zeigte sich bei beiden
Nachfolgeuntersuchungen mit 18% zu t2 und 38% zu t3. Prädiktoren
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Research Article OPEN ACCESSpsychischer Erkrankung waren geringe soziale Unterstützung nach
Krebstherapie,einniedrigeskörperlichesFunktionsniveau,Metastasen
oderandereernsteKomplikationensowiederVerlustsportlicherAktivi-
tät.
Schlussfolgerung:PersistenzundNeuauftretenpsychischerKrankheiten
auch im späten zeitlichen Verlauf nach Krebsdiagnose sollten bei der
Behandlung von Krebspatienten beachtet werden – insbesondere bei
Vorhandensein von Risikofaktoren.
Schlüsselwörter: psychiatrische Erkrankung, DSM-IV, Krebs, Verlauf,
Prädiktoren
Introduction
Various reviews on psychological adjustment to a cancer
diagnosis have demonstrated that about one third of
cancerpatientssufferfromapsychiatricdisorder[1],[2],
[3], [4]. It has also been shown in particular studies that
psychiatricmorbidityincancerpatientsmaybenegatively
associated with the patients’ quality of life [5], [6], the
duration of hospitalization [7], [8], the compliance with
anti-cancer treatment [9], [10], mortality [11], and the
risk of suicide [12].
Prevalences however, vary significantly depending on
patient characteristics (e.g. type of cancer, stage of dis-
ease, age and sex) and methods of investigation (e.g. in-
terview versus questionnaire). Structured interviews,
based on current nosographic classifications as DSM-IV
or ICD-10 are considered to be the 'gold standard' to re-
gisterthecriteriaofaformalpsychiatricdiagnosis.Table1
summarizestheresultsofrecentstudiesthatcomplywith
this requirement. All of these studies are cross-sectional
indesign,displayingratesofmentaldisordersatacertain
pointoftimesincediagnosisortreatment.However,little
is known about a longitudinal perspective on psychiatric
symptoms.Availablestudiesonclinicalcoursecommonly
featureonlyshortfollow-upintervals(uptooneyear)[13],
[14],[15],[16],[17]orfindingswereraisedwithoutusing
a structured interview for diagnosis [18], [19], [20], [21],
[22], [23].
Yetthelong-termcourseofpsychiatricdisordersincancer
patientscouldbevitallyimportantforplanningandreview-
ing psychosocial interventions: knowledge about course
characteristics as progression, regression or frequent
transitions between different disorders could influence
the choice of interventions to be applied for addressing
these problems.
Tothebestofourknowledge,thereareonlythreestudies
that describe the course of psychiatric disorders in a
prospective way during the period of at least one year,
employingdiagnosticsbasedonstructuredinterviewsas
mentioned above:
• Uchitomi et al. assessed 212 non-small cell lung can-
cer (NSCLC) patients 1, 3, and 12 months after cura-
tive resection [24]. The prevalence of depression did
not change significantly in the year after surgery (8%,
5% and 5% respectively). However, major depression
decreased while minor depression stayed constant.
Other disorders had not been taken into account in
this report.
• Akechi et al. investigated prevalence, predictors and
changeofadjustmentdisorders(AD),majordepression
(MD) and post-traumatic stress disorder (PTSD) in 85
terminally ill cancer patients [25]. At baseline, 16% of
the patients showed symptoms of AD and 7% had
symptoms of MD. PTSD had not been diagnosed. At
follow-up, 11% were diagnosed with AD and 12% with
MD. About 30% of all patients had changed in their
initialdiagnosis(including“none”),showingallpossible
transitions with an emphasis on changes from MD to
AD. It may be criticized however, that time to follow-up
had a wide range from 7 to 633 days and a median
of only 58 days. Anxiety disorders (other than PTSD)
have not been taken into account.
• Burgess et al. evaluated prevalence and predictive
factors of anxiety and depression in 170 patients with
breast-cancer [26]. During a five-year period, these
women were interviewed four times to cover the com-
pleteinterval.Pointprevalenceofdepressionwas33%
at diagnosis, 24% at three months and around 15%
after12monthsandbeyond.Theone-year-prevalences
droppedcontinuouslyfrom48%inthefirstyearto15%
in the fifth year. Unfortunately, the course of anxiety
and depression had not been displayed separately in
this study, as the course of anxiety levels is discussed
controversiallyinliteraturewithreferencestoconstant
levels of anxiety even more than 12 months after
cancer diagnosis [19], [21].
Associated or predictive factors of psychiatric disease
include demographic [24], [26], psychosocial [18], [26]
andbiomedicalvariables[20],[27].Psychosocialfactors
like social support, own children or psychiatric distress
in patient's history were generally reported to have a
higherimpactonpredictionofmentaldisordersincancer
patients than biomedical factors like cancer state, age
or sex [18], [26]. Naturally, most of these factors have
been found in relation to short term investigations and
may not necessarily predict psychiatric disease several
years after cancer treatment.
Summarizing, there is a lack of studies featuring long-
term assessment of psychiatric disease in cancer pa-
tients, covering a broad range of diagnoses, and employ-
ing high-quality instruments.
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Therefore, in our study, newly diagnosed cancer patients
were followed for three years, assessing psychiatric
morbiditywithastructuredinterviewbasedonacompre-
hensiverangeofDSM-IVdiagnoses.Furthermore,factors
predictive of psychiatric disease during three years after
cancer diagnosis have been identified using reliable and
valid instruments.
Patients and methods
Sample and design
The primary sample (n=689) was formed consecutively
from individuals with a cancer diagnosis who had under-
gone inpatient treatment between June 2002 and July
2004 in a hospital affiliated to the University of Leipzig
(visceral surgery, urology, radiotherapy and gynaecology)
orthematernityclinicofthecommunityhospitalSt.Georg
(Leipzig). The eligibility criteria for patient recruitment in
the study were: 1) age 18 years or older, 2) newly dia-
gnosed cancer with curative therapy approach, 3) know-
ledgeofcancerdiagnosis,4)beinginacceptablephysical
andmentalconditiontocompletethequestionnairesand
participate in an interview taking at least 45 minutes,
and 5) having sufficient verbal communication skills in
Germanlanguage.Concerningcriterion(4),eligibilitywas
discussed by physicians and investigators on a case-by-
casebasistoavoidbiasedjudgementandselectionbias.
The study was approved by the local Ethics committee of
the University of Leipzig and funded by The German
FederalMinistryforEducationandResearch.Eachpatient
was informed both verbally and in written form about the
goals of the study, the voluntary nature of their participa-
tion and the confidentiality of information shared.
Generaldemographicandclinicalcharacteristics,includ-
ingage,sex,tumoursite,UICCstate(UnionInternationale
ContreleCancer)andtypeoftherapywereobtainedfrom
patients'medicalcharts,whereassocio-demographicat-
tributes as income, educational level, having a partner
or family and religious and national affiliations were re-
trieved using an additional questionnaire. Then, psycho-
logical measurement using a semi-structured interview
was arranged during the first three days after admission
(baseline, t1).
As a result of economic limitations of the study, only
n=100patientslivingnearthecitycentreofLeipzigcould
be included for follow-up examinations. They were selec-
ted by random, minimizing the distance of their domicile
to the city centre. Thus, first follow-up examination (t2)
was conducted 6 to 18 months after t1 on n=100 local
residents of Leipzig and second follow-up (t3) was ar-
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participatedbothatt1andt2.Atbothfollow-upsacompre-
hensive evaluation of the patient's mental disorders had
been carried out using a semi-structured interview. This
interview was also used at t3 to investigate patients' his-
tory of psychiatric disorders, i.e. whether a mental dis-
order was present before diagnosis of cancer (lifetime).
Additionally, certain aspects of quality of life (including
physical functioning, pain and social well-being) were
assessedusingtwoquestionnairestogatherinformation
on potential correlations of psychiatric morbidity.
Information concerning death dates and current postal
address was provided by the local census bureau. Parti-
cipants were interviewed by a psychologist, interviews
took place in hospital at baseline and at home during
follow-up examinations.
Assessment instruments
Psychiatric morbidity
To cover a broad range of information about patients’
psychiatric disorders in a standardized way, the Struc-
tured Clinical Interview based on the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) was ad-
ministered to assess psychiatric morbidity. The variant
used in the present investigation was the Structured
Clinical Interview for DSM-IV, German Version [28], a
translation and adaptation of the ‘Structured Clinical In-
terview for DSM-IV – Research Version (SCID-1, Version
2.0)’. The interview provides the diagnosis of affective
disorders (including major depression and dysthymia),
anxietydisorders(includingpanicdisorder,socialphobia,
specificphobia,posttraumaticstressdisorderandgener-
alizedanxietydisorder),stressdisorders(includingacute
stress disorder and adjustment disorder), and screens
for substance abuse (including pharmaceuticals, drugs,
nicotine and alcohol). To constitute a diagnosis, certain
criteria have to be met, including severity and duration
of symptoms and their impact on everyday activities -
taking into account that symptoms should not be direct
physiological result of intoxication or general medical
factors. The reliability of SCID has been reported to be
satisfactory [29] and is commonly used for validation for
other psychiatric diagnostic instruments [30], [31]. Co-
hen’s kappa was used to assess interrater reliability for
45 randomly selected interviews in this study. Interrater
agreement for all current diagnoses was κ=0.95
(SD=0.12).
Demographic, biomedical and psychosocial
attributes
Tofindpotentialfactorsassociatedwithmentaldisorders,
demographic (sex, age, social affiliation, marital status,
number of children, nationality, membership of religious
group), psychosocial and biomedical data (UICC stage,
tumourlocalization,typeoftreatment,cancerrecurrence,
history of psychiatric treatment) were recorded in this
study. While most of the biomedical and demographic
data were registered during inpatient admission as de-
scribedabove,selectedpsychosocialcharacteristicswere
asked for at second follow-up, employing certain scales
of two questionnaires: 1) The European Organisation for
Research and Treatment of Cancer Quality of Life Core
Questionnaire(EORTCQLQ-C30),whichisaquestionnaire
developed to assess the quality of life in cancer patients
[32]. Its scales “physical functioning” and “pain” used in
this investigation, take into account the physical ability
to master daily-life activities and subjects’ impairment
caused by pain, respectively. 2) The Functional Assess-
mentofCancerTherapy-General,whichisthecoremodule
of the Functional Assessment of Chronic Illness Therapy-
measurement system, a collection of Quality-of-Life
questionnaires targeted to the management of chronic
illness [33]. Its scale “Social/Family Well-Being” applied
in this study, informs about the degree of social support
and intimacy of relationships to other persons. Addition-
ally, single item questions concerning patients' satisfac-
tion with their job, their habitation, their financial situ-
ation,theextentofsportiveactivitiesandtheimportance
of spirituality were asked.
Statistical analysis
Intergroupdifferencesincategorical,nonparametric,and
continuous variables were tested with the chi-square
statistics(orFisher'sexacttestifapplicable),theWilcoxon
two-sample test, and the unpaired t test, respectively.
Binary logistic regression analysis with forward and
backwardselectionmethodwasusedtofindthepotential
predictors of psychiatric morbidity after diagnosis of
cancer. The model for logistic regression was tested for
goodness of fit with the Hosmer and Lemeshow test.
SPSS
® 13.0 (SPSS Inc. Chicago, IL, USA) and G*Power
®
2.0 (Faul, F. & Erdländer, E.) were used for data storage
and analysis.
Results
Sample characteristics
Of 689 patients who were interviewed during the first
three days after admission (baseline), n=100 local resi-
dents of the City of Leipzig were selected (see sample
and design for details) at first follow-up, which was con-
ducted5to18months(mean13months)afterbaseline.
At second follow-up (between 23 and 38 months after
baseline, mean 28 months), 20 patients were excluded
due to death (n=10) or insufficient physical or mental
conditions (n=10). An additional 16 patients could not
be contacted by mail or by telephone using updated ad-
dress information from local census bureaus and 2 pa-
tients refused further participation for other reasons.
Thus, the final study group consisted of 62 individuals
with a complete data set of three assessments.
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range = 34-84 years) and 66% were female. Table 2
showsthedemographicsforthesample.Theparticipants
were primarily German (92%), married or living with a
partner (63%), having own children (79%), middle class
(66%) and most were not members of a religious group
(73%).
Table 2: Demographic characteristics of participants
The medical characteristics are described in Table 3. In-
dividuals predominantly had stage II or III disease (61%
of classified tumours) and were suffering from breast or
urogenital cancer (66%). Most patients had undergone
surgery (66%). In all mentioned biomedical and socio-
demographic variables, the final sample did not differ
significantly from the sample at first follow-up.
Table 3: Medical characteristics of participants
Prevalence of mental disorders
At baseline, at least one DSM-IV diagnosis was given in
29% of the cases. At both follow-ups, the frequency of
psychiatric morbidity did increase (t2: 36%; t3: 44%). A
detailed report of diagnoses is illustrated in Table 4. Af-
fective disorders remained constant over time (t1: 13%,
t2: 13% and t3: 16%) but the prevalence of dysthymia in-
creased (t1: 0%, t2: 6% and t3: 13%), whereas major de-
pressive episodes occurred less frequently. Anxiety dis-
orders advanced from initially 8% to 27% at both follow-
ups. At t2, this class of disorders is predominated by
posttraumatic stress disorder (8%), generalized anxiety
disorder(10%)andpanicdisorder(10%).Att3,incontrast,
socialphobia(7%),specificphobia(10%)andgeneralized
anxiety disorder (11%) played the major role. Stress dis-
ordersoccurredonlyatbaseline(12%)andsecondfollow-
up (8%). Considerable substance abuse was found
throughout all points in time of investigation (t1: 15%, t2:
11% and t3: 13%).
Clinical course of psychiatric morbidity
In18%ofthecases,individualsnotsufferingfrompsychi-
atric morbidity at baseline, had a DSM-IV diagnosis at
first follow-up. At second follow-up, 38% of the patients
were newly diagnosed with mental illness. The rates of
psychiatric disorders did not decrease during the three
years after initial treatment of cancer (χ
2=1.49, df=1,
p=0.223, power=0.8 at an effect size=0.36. According
toconventionsforχ
2-testsaneffectsizeof0.3isregarded
as medium). A history of psychiatric morbidity before the
diagnosis of cancer was found in 26 (42%) individuals.
Duringthewholeperiodofinvestigation(upto38months
after clinical assessment), a total of 39 persons (63%)
were given a psychiatric diagnosis on at least one occa-
sion. For 20 of these individuals (51%) this was the first
occurrence of a psychiatric disease in lifetime. Individual
changes of the patients' DSM-IV diagnoses are shown in
Figure 1. Affective disorders were found predominantly
in patients with former affective disorder (5 of 8 subjects
at t2), anxiety disorder (4 of 10 subjects at t3) or were
newlydiagnosed(4of10subjectsatt3).Of17individuals
withananxietydisorderatt2(t3),7patientsweresuffering
from a stress disorder (anxiety disorder). At both follow-
ups another 7 patients with an anxiety disorder had no
DSM-IV diagnosis at baseline or t1, respectively. All three
patients with an acute stress disorder at second follow-
upweresufferingfromnewlydiagnosedmetastases(data
not shown). Substance abuse was found predominantly
in individuals with former substance abuse (5 of 7 sub-
jects at t2) or former anxiety disorder (6 of 8 subjects at
t3).
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Predictive factors for psychiatric
morbidity
During the period from baseline investigation to second
follow-up,39patients(63%)werediagnosedwithatleast
oneDSM-IVdiagnosis.Inrespectofdemographic,biomed-
icalandpsychosocialattributes,therewereseveraldiffer-
ences between patients with and without psychiatric
morbidity.Variablesatt3whichshowedap<0.1inunivari-
ate analysis were used as covariates in a binary logistic
regressionanalysismodeltofindthepredictorsofmental
disorders during up to 38 months after diagnosis of can-
cer. By binary logistic regression analysis, the following
four predictive variables could be found in both forward
and backward selection (power of 0.8 at an effect size
of 0.21): social support after cancer therapy (p=0.045)
and good physical functioning regarding daily activities
(p=0.067) were negatively correlated with psychiatric
morbidity, whereas metastases or other severe compli-
cations of treatment (p=0.004) and loss of sportive
activity (p=0.065) were positively correlated (Table 5).
This configuration had a Nagelkerke R
2 of 0.526 in for-
ward selection and a non-significant Hosmer-Lemeshow
chi square indicating reasonable model fit (χ
2=11.52,
df=8, p=0.989).
Table 5: Predictors of psychiatric morbidity at second follow-
up in cancer patients
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to18monthsafter(t2)and23to38monthsafter(t3)).Linesstandforindividualchangesofdiagnosisovertime,withthenumber
of patients at the dotted end of each line, respectively. Thick lines indicate main influences from a certain class of disorder
found at the previous assessment point. Multiple diagnoses were possible (therefore, numbers do not add up necessarily).
Discussion
The present investigation has the character of a pilot
study which prospectively assesses a broad range of
psychiatric diagnoses in a population of patients with
cancer during a 3-year period after initial treatment and
analysespredictivefactorsofpsychiatricmorbidityduring
this period. It was designed to retrieve data concerning
along-termclinicalcourseusingstandardizeddiagnostic
criteria with reliable and valid instruments that might be
useful for future research.
Ourfindingshowedthattheratesofpsychiatricdisorders
did not decrease during the three years after initial
treatmentofcancer.Whiletherateofpsychiatricmorbid-
ity at t1 is in line with results of other studies, our findings
of the follow-ups have to be discussed in more detail. In
ourstudy,prevalenceofanxietydisordersincreasedfrom
8% at baseline to 27% at first follow-up and stayed con-
stant in second follow-up. In contrast, Burgess et al. [26]
found a significant decrease of depression and anxiety
duringthesecondandthirdyearafterdiagnosisofbreast
cancer. However, a shortened version of SCID, focusing
on symptoms of depression and anxiety, had been used
inBurgess’investigationanditremainsunclearifdysthy-
mia and different kinds of anxiety disorders were taken
into account. Other studies reported a constant level of
anxiety over time [19], [20], [21], but did not use semi-
structured clinical interviews for investigation.
Another important point concerning anxiety disorders is
that they were likely to arise later than one year after
diagnosis of cancer: 41% of patients with an anxiety dis-
order at t2 or t3 had no DSM-IV diagnosis at baseline or
t2, respectively (7 out of 17 in each case). A considerable
part of late onsets has also been found for affective dis-
ordersandstressdisordersatsecondfollow-up,thelatter
being associated with the occurrence of metastases or
severecomplicationsoftreatment.Thedenovomanifest-
ationofpsychiatricdisordersatt2andt3showstheimport-
ance of observing psychological distress in cancer pa-
tients over years, even if they did not receive a DSM-IV
diagnosis at the time of cancer occurrence.
Affectivedisordersremainedconstantovertime.However,
the prevalence of dysthymia increased, whereas major
depressiveepisodesoccurredlessfrequently.Thisfinding
is compatible with other studies [19], [24]: the severity
of depressive symptoms decreases and gives way for
milder, but chronic dysthymia. Noticeable, however, are
rates of adjustment disorders below 5% found in this
study,comparedtoreportedratesofupto28%[34].This
might have one of the following reasons: 1) in investiga-
tions using a limited range of diagnoses, adjustment
disorderscouldhavebeenusedasacontainerdiagnosis,
e.g.casesthatcouldhavebeendiagnosedasacutestress
reaction or minor depression were diagnosed as adjust-
ment disorder with anxiety or depressed mood, respect-
ively. 2) Adjustment disorders are clinically significant as
evidenced by either “distress that is in excess of what
would be expected from exposure to the stressor” or
“significant impairment in social, occupational or educa-
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able range of interpretation [17].
Predictors of psychiatric morbidity during a 3-year period
after cancer diagnosis were a lack of social support, oc-
currence of metastases or other severe complications,
insufficient physical function in daily life activities and
lossofsportiveactivityaftercancertreatment.Exceptfor
the occurrence of metastases, these predictors are in
line with the assertion made in the introduction, that
psychosocial factors have a higher impact on prediction
of mental disorders in cancer patients than biomedical
factors. However, patients with recurrence have been
described in the literature as experiencing a sharp in-
crease in levels of anxiety and depression [26].
Our study has several limitations. First of all, since the
sample size of individuals participating in the first follow-
up had to be reduced seriously due to economic limita-
tions of the study (n=100, 15 % of initial sample size
n=689) and a drop-out of 38% was recorded at t3 (n=62,
9%ofinitialsamplesize),generalizingtheresultsindetail
may not be possible. On the other hand, our sample
differedonlyinsex(morefemales)andcancerlocalisation
(more breast cancer) from the sample of all cancer pa-
tients assessed during the period of investigation
(n=689).Althoughtheroleofsexdifferencesisdiscussed
controversially,areviewarticle[35]andourownfindings
found no sex differences in prevalence of psychiatric
morbidity in cancer patients. Second, the selection of
urban inhabitants at first follow-up (which was also due
to economic limitations) might have led to a bias against
rural populations. Third, the time span of each follow-up
assessment is large (12 months), which impairs the
comparability within the sample. At a given time gap of
at least 6 months between follow-ups, grouping of the
patients still seemed justifiable, though. Furthermore,
theneedoftreatmentofspecificphobiaandsocialphobia
isdiscussedcontroversiallyandmayputintoperspective
the considerable increase of these disorders at both fol-
low-ups. However, at least social phobia in the context of
impairedfunctionandalteredappearanceaftertreatment
(e.g. head and neck surgery) is a well-known indication
forpsychologicalintervention.Evenspecificphobia,such
as agoraphobia, may have essential consequences for
tomography and other techniques where the patient has
to lay quietly in a narrow tube for quite a long period of
time. Finally, conducting a regression analysis with a
sample size of 62 may be of low significance. In our ex-
ample, the analysis had a power of 0.8 at an effect size
of0.21(accordingtoconventionsforregressionanalyses
an effect size of 0.15 is regarded as medium).
Notwithstandingtheselimitations,itmaybesummarized
that both, noticeable persistence and amount of newly
diagnosed psychiatric disorders during three years after
cancer treatment should be considered in the treatment
of cancer patients, especially in individuals with positive
predictive factors. As a matter of course, small sample
size and high drop-out rate constitute the preliminary
characterofthisstudy.Yetitcouldbeshown,thatpsychi-
atric disorders may prevail or arise even years after can-
cerdiagnosis.Tolearnmoreaboutthetemporalpatterns
of psychiatric disorders in cancer patients, and to effi-
ciently provide professional psychological support, more
well-designed long-term studies with larger numbers of
participants are desirable.
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